Respiratory syncytial virus vaccine(Moderna Therapeutics)

Generic Name: Respiratory syncytial virus vaccine(Moderna Therapeutics)

Clinical Trials

A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated Mothers

Phase 2

Active, not recruiting

Conditions: Respiratory Syncytial Virus

Interventions: Biological: mRNA-1345
Biological: Placebo

First Posted Date: 2023-11-22

Last Posted Date: 2025-03-13

Lead Sponsor: ModernaTX, Inc.

Target Recruit Count: 360

Registration Number: NCT06143046

Locations: 🇺🇸
Clinical Research Prime - ClinEdge - PPDS, Idaho Falls, Idaho, United States
🇺🇸
Bingham Memorial Hospital, Pocatello, Idaho, United States
🇺🇸
SEC Clinical Research LLC - Dothan 2 - ClinEdge - PPDS, Dothan, Alabama, United States

and more 53 locations

A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus

Phase 2

Active, not recruiting

Conditions: Respiratory Syncytial Virus

Interventions: Biological: mRNA-1345
Biological: Placebo

First Posted Date: 2023-10-24

Last Posted Date: 2025-03-21

Lead Sponsor: ModernaTX, Inc.

Target Recruit Count: 346

Registration Number: NCT06097299

Locations: 🇺🇸
Javara, Inc., Fayetteville, Georgia, United States
🇺🇸
ASCADA Research, LLC - Family Medicine, Fullerton, California, United States
🇺🇸
Velocity Clinical Research Metairie, Metairie, Louisiana, United States

and more 47 locations

A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults

Phase 3

Active, not recruiting

Conditions: Respiratory Syncytial Virus

Interventions: Biological: mRNA-1345

First Posted Date: 2023-10-04

Last Posted Date: 2024-11-15

Lead Sponsor: ModernaTX, Inc.

Target Recruit Count: 1150

Registration Number: NCT06067230

Locations: 🇺🇸
Lenzmeier Family Medicine - CCT - PPDS, Glendale, Arizona, United States
🇺🇸
Foothills Research Center - CCT - PPDS, Phoenix, Arizona, United States
🇺🇸
Fiel Family & Sports Medicine - PC - CCT - PPDS, Tempe, Arizona, United States

and more 41 locations

A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months

Phase 1

Active, not recruiting

Conditions: Respiratory Syncytial Virus
Human Metapneumovirus

Interventions: Biological: mRNA-1345
Biological: mRNA-1365
Biological: Placebo
Drug: Nimenrix

First Posted Date: 2023-02-24

Last Posted Date: 2024-12-02

Lead Sponsor: ModernaTX, Inc.

Target Recruit Count: 310

Registration Number: NCT05743881

Locations: 🇺🇸
Los Angeles Children's Hospital, Los Angeles, California, United States
🇺🇸
Palmetto Pediatrics, PA, North Charleston, South Carolina, United States
🇿🇦
Family Centre for Research with Ubuntu (FAMCRU)- Tygerberg, Cape Town, Western Cape, South Africa

and more 52 locations

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Adults

Phase 2

Recruiting

Conditions: Influenza

Interventions: Biological: mRNA-1010
Biological: Egg-based Quadrivalent Influenza Vaccine
Biological: Adjuvanted Quadrivalent Influenza Vaccine
Biological: Inactivated Influenza Vaccine
Biological: mRNA-1045
Biological: mRNA-1345

First Posted Date: 2022-11-07

Last Posted Date: 2025-03-11

Lead Sponsor: ModernaTX, Inc.

Target Recruit Count: 325

Registration Number: NCT05606965

Locations: 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States

Moderna Vaccine mRNA-1345 Observational Respiratory Syncytial Virus (RSV) Study

Completed

Conditions: Respiratory Syncytial Virus

Interventions: Biological: Placebo
Biological: mRNA-1345

First Posted Date: 2022-10-10

Last Posted Date: 2025-01-24

Lead Sponsor: ModernaTX, Inc.

Target Recruit Count: 10994

Registration Number: NCT05572658

Locations: 🇺🇸
Tekton Research - Longmont - Platinum - PPDS, Longmont, Colorado, United States
🇺🇸
Seattle Womens: Health, Research, Gynecology, Seattle, Washington, United States
🇺🇸
Hope Research Institute LLC - Hunt - PPDS, Tempe, Arizona, United States

and more 103 locations

A Study of Modified mRNA Vaccines in Healthy Adults

Phase 1

Active, not recruiting

Conditions: SARS-CoV-2
Respiratory Syncytial Virus
Cytomegalovirus
Seasonal Influenza

Interventions: Biological: mRNA-1345
Biological: mRNA-1647
Biological: mRNA-1273
Biological: FLUAD®
Biological: mRNA-1010

First Posted Date: 2022-05-31

Last Posted Date: 2025-03-24

Lead Sponsor: ModernaTX, Inc.

Target Recruit Count: 308

Registration Number: NCT05397223

Locations: 🇺🇸
Johnson County Clinical Trials, Lenexa, Kansas, United States
🇺🇸
Benchmark Research, Austin, Texas, United States
🇺🇸
Tekton Research, Inc, Austin, Texas, United States

and more 3 locations

A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age

Phase 3

Completed

Conditions: Respiratory Syncytial Virus

Interventions: Biological: mRNA-1345
Biological: Placebo
Biological: Afluria® Quadrivalent
Biological: mRNA-1273.214

First Posted Date: 2022-04-15

Last Posted Date: 2025-03-25

Lead Sponsor: ModernaTX, Inc.

Target Recruit Count: 3317

Registration Number: NCT05330975

Locations: 🇺🇸
Floridian Clinical Research - ClinEdge - PPDS, Miami Lakes, Florida, United States
🇺🇸
Suncoast Research Associates LLC - ERN - PPDS, Miami, Florida, United States
🇺🇸
Santa Rosa Medical Centers of Nevada - CCT Research, Las Vegas, Nevada, United States

and more 58 locations

A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age

Phase 2

Active, not recruiting

Conditions: Respiratory Syncytial Virus

Interventions: Drug: Placebo
Drug: mRNA-1345

First Posted Date: 2021-11-19

Last Posted Date: 2024-05-31

Lead Sponsor: ModernaTX, Inc.

Target Recruit Count: 36814

Registration Number: NCT05127434

Locations: 🇺🇸
HEALOR Primary Care - Physicians Las Vegas - CCT, Las Vegas, Nevada, United States
🇺🇸
Velocity Clinical Research - Cincinnati - PPDS, Cincinnati, Ohio, United States
🇺🇸
AES - DRS - Synexus Clinical Research US, Inc. - Cincinnati, Cincinnati, Ohio, United States

and more 263 locations

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy